Label-Free Quantitative Proteomics Analysis of Adriamycin Selected Multidrug Resistant Human Lung Cancer Cells

Overview

Journal Biomolecules

Publisher MDPI

Specialties Biochemistry
Molecular Biology

Date 2022 Oct 27

PMID 36291610

Authors

Esen Efeoglu

Michael Henry

Martin Clynes

Paula Meleady

Affiliations

Soon will be listed here.

Abstract

The development of drug resistance in lung cancer is a major clinical challenge, leading to a 5-year survival rate of only 18%. Therefore, unravelling the mechanisms of drug resistance and developing novel therapeutic strategies is of crucial importance. This study systematically explores the novel biomarkers of drug resistance using a lung cancer model (DLKP) with a series of drug-resistant variants. In-depth label-free quantitative mass spectrometry-based proteomics and gene ontology analysis shows that parental DLKP cells significantly differ from drug-resistant variants, and the cellular proteome changes even among the drug-resistant subpopulations. Overall, ABC transporter proteins and lipid metabolism were determined to play a significant role in the formation of drug resistance in DKLP cells. A series of membrane-related proteins such as HMOX1, TMB1, EPHX2 and NEU1 were identified to be correlated with levels of drug resistance in the DLKP subpopulations. The study also showed enrichment in biological processes and molecular functions such as drug metabolism, cellular response to the drug and drug binding. In gene ontology analysis, 18 proteins were determined to be positively or negatively correlated with resistance levels. Overall, 34 proteins which potentially have a therapeutic and diagnostic value were identified.

Citing Articles

DHFR2 RNA directly regulates dihydrofolate reductase and its expression level impacts folate one carbon metabolism.

Drago P, Bookey N, Leung K, Henry M, Meleady P, Greene N FASEB J. 2025; 39(4):e70391.

PMID: 39957677 PMC: 11831416. DOI: 10.1096/fj.202401039RR.

The role of sialidase Neu1 in respiratory diseases.

Mei S, Li D, Wang A, Zhu G, Zhou B, Li N Respir Res. 2024; 25(1):134.

PMID: 38500102 PMC: 10949680. DOI: 10.1186/s12931-024-02763-9.

Transmembrane and Ubiquitin-Like Domain-Containing 1 Promotes Glioma Growth and Indicates Unfavorable Prognosis.

Liu Y, Cai C, Wu K, Hu L Int J Genomics. 2023; 2023:3318171.

PMID: 38148953 PMC: 10751162. DOI: 10.1155/2023/3318171.

Targeting protein glycosylation to regulate inflammation in the respiratory tract: novel diagnostic and therapeutic candidates for chronic respiratory diseases.

Xie X, Kong S, Cao W Front Immunol. 2023; 14:1168023.

PMID: 37256139 PMC: 10225578. DOI: 10.3389/fimmu.2023.1168023.

References

Hillebrand M, Gersting S, Lotz-Havla A, Schafer A, Rosewich H, Valerius O . Identification of a new fatty acid synthesis-transport machinery at the peroxisomal membrane. J Biol Chem. 2011; 287(1):210-221. PMC: 3249072. DOI: 10.1074/jbc.M111.272732. View

Belvedere R, Bizzarro V, Forte G, Dal Piaz F, Parente L, Petrella A . Annexin A1 contributes to pancreatic cancer cell phenotype, behaviour and metastatic potential independently of Formyl Peptide Receptor pathway. Sci Rep. 2016; 6:29660. PMC: 4944142. DOI: 10.1038/srep29660. View

Dagogo-Jack I, Shaw A . Tumour heterogeneity and resistance to cancer therapies. Nat Rev Clin Oncol. 2017; 15(2):81-94. DOI: 10.1038/nrclinonc.2017.166. View

Fernandez L, Merino M, Colmenarejo G, Moreno-Rubio J, Sanchez-Martinez R, Quijada-Freire A . Metabolic enzyme ACSL3 is a prognostic biomarker and correlates with anticancer effectiveness of statins in non-small cell lung cancer. Mol Oncol. 2020; 14(12):3135-3152. PMC: 7718959. DOI: 10.1002/1878-0261.12816. View

Pizer E, WOOD F, Heine H, Romantsev F, Pasternack G, Kuhajda F . Inhibition of fatty acid synthesis delays disease progression in a xenograft model of ovarian cancer. Cancer Res. 1996; 56(6):1189-93. View

Piskareva O, Harvey H, Nolan J, Conlon R, Alcock L, Buckley P . The development of cisplatin resistance in neuroblastoma is accompanied by epithelial to mesenchymal transition in vitro. Cancer Lett. 2015; 364(2):142-55. DOI: 10.1016/j.canlet.2015.05.004. View

Oshi M, Tokumaru Y, Mukhopadhyay S, Yan L, Matsuyama R, Endo I . Annexin A1 Expression Is Associated with Epithelial-Mesenchymal Transition (EMT), Cell Proliferation, Prognosis, and Drug Response in Pancreatic Cancer. Cells. 2021; 10(3). PMC: 8000658. DOI: 10.3390/cells10030653. View

Fhu C, Ali A . Fatty Acid Synthase: An Emerging Target in Cancer. Molecules. 2020; 25(17). PMC: 7504791. DOI: 10.3390/molecules25173935. View

Della Fazia M, Castelli M, Bartoli D, Pieroni S, Pettirossi V, Piobbico D . HOPS: a novel cAMP-dependent shuttling protein involved in protein synthesis regulation. J Cell Sci. 2005; 118(Pt 14):3185-94. DOI: 10.1242/jcs.02452. View

10.

Crawford R, Potukuchi P, Schuetz E, Schuetz J . Beyond Competitive Inhibition: Regulation of ABC Transporters by Kinases and Protein-Protein Interactions as Potential Mechanisms of Drug-Drug Interactions. Drug Metab Dispos. 2018; 46(5):567-580. PMC: 5896366. DOI: 10.1124/dmd.118.080663. View

11.

Liu D, Fu X, Wang Y, Wang X, Wang H, Wen J . Protein diaphanous homolog 1 (Diaph1) promotes myofibroblastic activation of hepatic stellate cells by regulating Rab5a activity and TGFβ receptor endocytosis. FASEB J. 2020; 34(6):7345-7359. PMC: 7686927. DOI: 10.1096/fj.201903033R. View

12.

Law E, Gilvarry U, Lynch V, Gregory B, Grant G, Clynes M . Cytogenetic comparison of two poorly differentiated human lung squamous cell carcinoma lines. Cancer Genet Cytogenet. 1992; 59(2):111-8. DOI: 10.1016/0165-4608(92)90204-l. View

13.

Onozawa H, Saito M, Saito K, Kanke Y, Watanabe Y, Hayase S . Annexin A1 is involved in resistance to 5-FU in colon cancer cells. Oncol Rep. 2016; 37(1):235-240. DOI: 10.3892/or.2016.5234. View

14.

Clynes M, Daly C, Nicamhlaoibh R, Cronin D, Elliott C, OConnor R . Recent developments in drug resistance and apoptosis research. Crit Rev Oncol Hematol. 1998; 28(3):181-205. DOI: 10.1016/s1040-8428(98)00018-3. View

15.

Chen J, Guccini I, Di Mitri D, Brina D, Revandkar A, Sarti M . Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer. Nat Genet. 2018; 50(2):219-228. PMC: 5810912. DOI: 10.1038/s41588-017-0026-3. View

16.

Fu H, Xu J, Chen J, Li G, Zhao X, Chen P . Microarray analysis reveals Tmub1 as a cell cycle-associated protein in rat hepatocytes. Mol Med Rep. 2018; 17(3):4337-4344. PMC: 5802207. DOI: 10.3892/mmr.2018.8451. View

17.

Cevatemre B, Ulukaya E, Dere E, Dilege S, Acilan C . Pyruvate Dehydrogenase Contributes to Drug Resistance of Lung Cancer Cells Through Epithelial Mesenchymal Transition. Front Cell Dev Biol. 2022; 9:738916. PMC: 8785343. DOI: 10.3389/fcell.2021.738916. View

18.

Cole S, Bhardwaj G, Gerlach J, MACKIE J, Grant C, Almquist K . Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science. 1992; 258(5088):1650-4. DOI: 10.1126/science.1360704. View

19.

Keenan J, Murphy L, Henry M, Meleady P, Clynes M . Proteomic analysis of multidrug-resistance mechanisms in adriamycin-resistant variants of DLKP, a squamous lung cancer cell line. Proteomics. 2009; 9(6):1556-66. DOI: 10.1002/pmic.200800633. View

20.

Haxho F, Neufeld R, Szewczuk M . Neuraminidase-1: a novel therapeutic target in multistage tumorigenesis. Oncotarget. 2016; 7(26):40860-40881. PMC: 5130050. DOI: 10.18632/oncotarget.8396. View